<<>>>
TitleUrlVersionPublisher
Ceritinibhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.18020150910CancerLinQ Steward
Malignant Neoplasm of Bone, Connective Tissue Skin (Other than Malignant Melanoma of the Skin) and Breasthttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.101320170826NCQA PHEMUR
COVID19 SNOMED Value Set for Adult Rheumatoid Arthritishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.600820221207Clinical Architecture
Tonometryhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.56020200319ASRS Quality Measure Development Steward
Hospice Services Received During Measurement Period (HCPCS)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.18420201129American Academy of Neurology Steward
Fatigue/Weakness/Malaise (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86020200515CSTE Steward
Pregnancy Ending in Deliveryhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.11720210416NACHC Steward
Confirmed as Currenthttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.122.12.103820160205NCQA PHEMUR
Gestational Diabeteshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.103.11.101420130614NCQA PHEMUR
Hepatitis D Virus Infection (Organism or Substance in Lab Results)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.197320230125CSTE Steward
Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.206220230125CSTE Steward
Mammography_HD_ICD9http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.13520220825B.well Connected Health Steward
Angerhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.108120210924HL7 Patient Care WG Steward
Hospice Care Referral or Admissionhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.36520191010CancerLinQ Steward
Diffuse Parenchymal Lung Diseasehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.109020190105Oncology Nursing Society Steward
Chronic Hepatitis Chttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.6620190308AGA Steward
Inotuzumab Ozogamicin Injectablehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.16620210521American Society of Clinical Oncology Steward
Moderate Respiratory complications with LOS Procedureshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.18620240514Joint Commission
Macrolideshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.83220240226Optum Steward
Excision of Skin Lesionhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1434.103620160311CAP Steward
Hospital Measures-Myelogenic leukemiahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.103020121025Lantana
Patient is Ambulatoryhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.120020170826NCQA PHEMUR
SARS Coronavirus 2 Antibody Panelshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.503920200723Clinical Architecture
Bone Scanhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.12620240130Mathematica
COVID19 SNOMED Value Set for Alanine Aminotransferase (ALT), Bld/Ser/Plashttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.601020200710Clinical Architecture
Locoregional Urothelial Cancerhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12720240216CancerLinQ Steward
COVID19 SNOMED Value Set for Dyspneahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.610520221207Clinical Architecture
Drug Overdose and Poisoning [Suspected] (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.107520191228CSTE Steward
Epilepsy: Women of childbearing potentialhttp://cts.nlm.nih.gov/fhir/ValueSet/113883.202720180628American Academy of Neurology Steward
Medication Management (ADL or IADL)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96420210922HL7 Patient Care WG Steward
<<>>>718719720721722<<>>>